Loading this company
Glenmark Pharmaceuticals Limited
GLENMARK.NSPrices in INR
TickerWorth ScoreA64/100
What we think
Priced within our range of ₹801.88 to ₹3,185.77.
Price
₹2,210.20INR down −₹16.50 (−0.74%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 13:20 UTC (5 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
₹801.88–₹3,185.77
What the price needs: revenue growth of 9.1%/yr for 5 years (our model assumes 13.4%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price ₹2,210.20Priced · Prices are delayed.
Is it a good business?
- Valuation50 out of 100
- Growth100 out of 100
- Financial health100 out of 100
- Dividend75 out of 100
- Past performance100 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
₹2,512.82 across 11 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Glenmark Pharmaceuticals Limited, together with its subsidiaries, research, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides various products in the therapeutic areas of dermatology, respiratory, oncology, cardiology, diabetes, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, and respiratory-metered dose inhaler, dry powder inhaler, and nasal sprays. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in India. The company employs roughly 16,946 people.
Key stats
52-week range₹1,792.60–₹2,537.60
- Open
- ₹2,230.10
- Day high
- ₹2,269.90
- Day low
- ₹2,200.00
- Previous close
- ₹2,226.70
- Volume
- 285,701 · 0.52× avg
- Average volume
- 554,736
- Market cap
- ₹623,772,958,720.00
- P/E (TTM)
- 34.70
- Earnings per share
- ₹63.69
- Beta
- 0.25
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
No filings or corporate activity on file in the recent window.
Top news
No recent headlines we can cite for this company.
Insider trades
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.